MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above

C4XD, e-therapeutics identify new ways to discover potential Packinson Disease treatments

C4X Discovery Holdings and e-therapeutics said Thursday they had identified novel approaches to drug targets for the potential treatment of Parkinson's Disease.

Both companies said further work in this area had 'the potential to transform the treatment landscape for these patients.'

'Following the identification of novel drug targets for the treatment of PD from the direct findings from our Taxonomy3 platform we recognise there still remains untapped potential in this proprietary analysis,' said Craig Fox, Chief Scientific Officer at C4XD.

'By working with the team at e-therapeutics and utilising their NDD platform, we have been able to access cutting-edge mathematical and data analysis techniques to augment and interrogate the vast amount of biological information currently available in both public and private databases. This combination has identified additional novel biological pathways for the treatment of PD and we look forward to moving these findings forward to initiate new drug discovery programmes.'

At 8:11am: (LON:C4XD) C4x Discovery Holdings Plc share price was 0p at 72.5p

Story provided by